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Schizophrenia is characterized by neuropsychological 
deficits across many cognitive domains. Cognitive phe-
notypes with high heritability and genetic overlap with 
schizophrenia liability can help elucidate the mechanisms 
leading from genes to psychopathology. We performed a 
meta-analysis of 170 published twin and family heritabil-
ity studies of >800 000 nonpsychiatric and schizophrenia 
subjects to accurately estimate heritability across many 
neuropsychological tests and cognitive domains. The pro-
portion of total variance of each phenotype due to additive 
genetic effects (A), shared environment (C), and unshared 
environment and error (E), was calculated by averaging A, 
C, and E estimates across studies and weighting by sample 
size. Heritability ranged across phenotypes, likely due to 
differences in genetic and environmental effects, with the 
highest heritability for General Cognitive Ability (32%–
67%), Verbal Ability (43%–72%), Visuospatial Ability 
(20%–80%), and Attention/Processing Speed (28%–74%), 
while the lowest heritability was observed for Executive 
Function (20%–40%). These results confirm that many 
cognitive phenotypes are under strong genetic influences. 
Heritability estimates were comparable in nonpsychiatric 
and schizophrenia samples, suggesting that environmen-
tal factors and illness-related moderators (eg, medication) 
do not substantially decrease heritability in schizophrenia 
samples, and that genetic studies in schizophrenia samples 
are informative for elucidating the genetic basis of cogni-
tive deficits. Substantial genetic overlap between cognitive 
phenotypes and schizophrenia liability (average rg = −.58) 
in twin studies supports partially shared genetic etiology. 
It will be important to conduct comparative studies in 
well-powered samples to determine whether the same or 
different genes and genetic variants influence cognition in 
schizophrenia patients and the general population.
Key words:  neuropsychology/heritability/  
meta-analysis/endophenotypes/twin study/cognition
Introduction
There is extensive evidence that cognition is significantly 
impaired in schizophrenia. Relative to healthy indi-
viduals, schizophrenia patients as a whole have a gen-
eralized impairment across many cognitive functions, 
demonstrated by meta-analyses of  over 200 schizo-
phrenia neuropsychological studies.1,2 At the individual 
patient level, 75%–100% of patients exhibit cognitive 
impairments, depending on the method of  classify-
ing deficits.3 A meta-analysis by Mesholam-Gately and 
colleagues4 of  neuropsychological functioning in first 
episode schizophrenia patients showed that, in the 
early stages of  disease when the brain is less affected 
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by antipsychotic medications, performance across sev-
eral cognitive domains is impaired on average 0.91 SDs 
below the healthy control mean. Individuals at clinical 
high-risk for psychosis are less impaired than first epi-
sode patients, although there are greater deficits in high-
risk individuals who later develop a full psychotic illness 
than those who do not.5,6 In addition, unaffected family 
members at genetic risk for developing the disorder have 
poorer cognition compared to unaffected individuals 
without a family history of  schizophrenia.7–10 Cognitive 
deficits are relatively unimproved by antipsychotic medi-
cations and consequently have a substantial impact on 
the functional outcome of patients.11–17 Elucidating the 
molecular mechanisms underlying cognition is essential 
for identifying novel targets for the development of  new 
treatments that improve cognitive functioning in patients 
with schizophrenia.
Recent advances in the field of  psychiatric genetics 
have led to the identification of  a large number of  com-
mon genetic variants that confer risk for schizophre-
nia.18–27 Determining how these risk variants contribute 
to brain-based phenotypes that are abnormal in schizo-
phrenia, such as cognitive deficits, can greatly contrib-
ute to our understanding of  the biological pathways 
leading from risk genes to disease. A  prerequisite for 
such studies is evidence that the phenotypes are heri-
table and have a genetic basis that overlaps with that 
of  schizophrenia liability.28–30 Measures of  General 
Cognitive Ability are highly heritable (h2 > 65%),31,32 
although there is less consistent evidence for heritabil-
ity of  measures indexing specific cognitive domains. 
Toulopoulou, Owens and colleagues estimated from a 
series of  twin studies that genetic correlations between 
cognitive measures and liability of  schizophrenia range 
between −.09 and −1.00, averaging −.58,33–38 indicating 
that a substantial proportion of  the variance in cog-
nition and schizophrenia liability is due to common 
genetic factors.
We performed a systematic review of  twin- and fam-
ily-based heritability studies of  cognitive phenotypes 
in schizophrenia and nonpsychiatric populations with 
several objectives in mind. Given the lack of  available 
quantitative studies, we performed meta-analyses of 
data available for many neuropsychological tests and 
cognitive domains to determine the best estimates of 
heritability. We determined whether studies of  nonpsy-
chiatric individuals and schizophrenia patients differ 
in heritability to examine whether, as claimed, herita-
bility in patients is lower due to environmental factors 
and illness-related moderators, such as higher rates of 
smoking and substance use, fluctuations in medication, 
or clinical state during testing.39–41 Further, as family 
studies cannot disentangle genetic and shared environ-
mental sources of  phenotypic variance, we compared 
variance component estimates from family and mono-
zygotic/dizygotic (MZ/DZ) twin study designs.
Methods
Detailed methods are provided in the supplementary 
material.
Data Collection
A literature search performed in PubMed and PsycINFO 
resulted in >2000 papers published prior to January 
2016. Following abstract review, identification of addi-
tional articles from the reference lists, and exclusion of 
studies according to pre-established criteria (supplemen-
tary methods, supplementary tables 1–4), 170 empirical 
articles describing twin or family studies were included 
in the analyses (supplementary figure  1). These studies 
investigated the heritability of >600 neuropsychological 
test variables in 64 independent cohorts (supplementary 
tables 1, 5–8). See supplementary material for a complete 
list of references included in the meta-analyses.
Statistical Analyses
We performed separate meta-analyses for studies of non-
psychiatric twins (129 studies), nonpsychiatric families 
(13), and schizophrenia families (22). We meta-analyzed 
neuropsychological test variables that were reported in at 
least 2 independent studies. Additionally, neuropsycho-
logical test variables were assigned to one of the following 
11 domains based on prior meta-analyses2,4 of cognition 
in schizophrenia: General Cognitive Ability, Attention/
Processing Speed, Attention/Vigilance, Working Memory, 
Verbal Learning and Memory, Nonverbal Learning and 
Memory, Executive Function, Verbal Ability, Visuospatial 
Ability, Motor Skills, and Social Cognition. Meta-
analyses of cognitive domains utilized all tests within a 
domain regardless of how many studies analyzed a par-
ticular test variable. If  multiple tests within a cognitive 
domain were available for a given cohort, we included the 
average estimates for additive genetic effects (A), common 
(shared) environment (C), as well as unique (unshared) 
environment and error (E) across those tests in the domain 
meta-analysis. Supplementary table 9 describes the tests 
included in this meta-analysis, the cognitive functions 
they assess, and the cognitive domains they index.
For each neuropsychological test or cognitive domain, 
the proportion of total variance accounted for by A, 
C, and E was calculated by averaging each component 
across studies from independent cohorts while weighting 
by sample size. Family studies without twins cannot dis-
tinguish the influences of A and C, therefore the estimate 
of familiality (A+C) was used as A. Heritability was cal-
culated as the proportion of total variance due to addi-
tive genetic effects (A/ A+C+E). All analyses were carried 
out in R (http://www.r-project.org) using custom scripts.
Wald tests42 were applied to identify significant differ-
ences in the heritability of cognitive phenotypes estimated 
from meta-analyses of schizophrenia and nonpsychiatric 
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family studies, and nonpsychiatric twin and family stud-
ies. P-values were Bonferroni-corrected for 15 phenotypes 
tested for each of the 2 comparisons (.05/15 = .0033).
Results
Twin Correlations as Indicators of Heritability
Supplementary figure 2 illustrates that nonpsychiatric MZ 
twin correlations for cognitive phenotypes averaged .58 
(range 0–.94), while DZ twin correlations averaged .32 
(range 0–.88), suggesting sizeable influences of A and E, 
and minor influences of C. General Cognitive Ability had 
the highest MZ/DZ correlation ratios (mean rMZ/ rDZ = .75/ 
.44), indicating that a large proportion of the variation can 
be attributed to A, consistent with reports of high heritabil-
ity.43 Although more variable, ratios for Verbal Ability and 
Visuospatial Ability were also high (.66/ .40 and .55/ .30).
Meta-analyses of Heritability of Cognitive Phenotypes
Nonpsychiatric Twins. The studies of nonpsychiat-
ric twins aged >16 (supplementary table 5) reported 375 
test variables from all 11 cognitive domains. Of these, 48 
variables from 8 domains were studied in 2–11 indepen-
dent cohorts and meta-analyzed. Heritability estimates 
ranged between 20% and 80% (figure 1). High heritabil-
ity (h2) was observed for measures of General Cognitive 
Ability (h2 = 53%) and the Index Scores obtained from the 
Wechsler Adult Intelligence Scale (WAIS) (h2 = 53%–80%), 
as well as WAIS Information (h2 = 63%), Block Design (h2 
= 60%), Digit Symbol Coding (h2 = 59%) and Arithmetic 
(h2 = 58%), Thurstone Picture Memory (h2 = 63%), and the 
Educational Testing Service (ETS) tests (h2 = 67%–74%). 
Overall, the cognitive domain showing the highest heri-
tability was Visuospatial Ability (h2 = 51%), followed by 
Verbal Ability (h2 = 41%) and Attention/Processing Speed 
(h2 = 45%), primarily driven by the high heritability of the 
WAIS subtests within each of these 3 domains.
Nonpsychiatric Families. The family studies of non-
psychiatric individuals (supplementary table 6) reported 
64 test variables from 10 of the 11 cognitive domains 
(except Motor Skills), of which 9 variables were studied 
in 2–3 independent family cohorts and meta-analyzed. 
Heritability estimates ranged from 30% to 55% (figure 2). 
Heritability was high for measures of General Cognitive 
Ability (h2  =  53%), as well as the IQ subtest scores of 
WAIS Letter–Number Sequencing (h2 = 55%) and WAIS 
Matrix Reasoning (h2  =  53%). Overall, the individual 
cognitive domains showing the highest heritability were 
Visuospatial Ability (h2  =  52%), which was primarily 
driven by the high heritability of Matrix Reasoning; and 
Verbal Ability (h2 = 52%).
Schizophrenia Families. The family studies of schizo-
phrenia (supplementary table  7) reported 155 test 
variables from all 11 cognitive domains, of which 41 vari-
ables were studied in 2–7 independent cohorts and meta-
analyzed. Heritability estimates ranged from 15 to 74% 
(figure 3). Heritability was high for measures of General 
Cognitive Ability (h2  =  63%) and WAIS Vocabulary 
(h2 = 74%), as well as WRAT Reading (h2 = 74%), often 
used as a proxy measure for premorbid IQ. Furthermore, 
high heritability was apparent for the Wechsler Memory 
Scale (WMS) subtest Logical Memory Immediate Recall, 
CVLT Long Delay Free Recall, Penn Word Memory, 
WAIS Block Design and Similarities, and Judgment of 
Line Orientation (h2  =  52%–62%). Overall, the cogni-
tive domain showing the highest heritability was Verbal 
Ability (h2  =  55%), followed by Visuospatial Ability 
(h2 = 51%), again driven mostly by the high heritability of 
the WAIS subtests within each domain.
Supplementary figures 3–13 show heritability data 
from individual studies included in the meta-heritability 
estimates. The forest plots show the heritability of indi-
vidual neuropsychological test variables and the over-
arching cognitive domains. The resulting meta-estimates 
of individual tests (bold) and domains (bold italic) cor-
respond to the data in figures 1–3.
In summary, twin and family studies show highest 
heritability for the following tests: WAIS Digit Symbol 
Coding, Letter–Number Sequencing, Digit Span, 
Vocabulary, Information, and Block Design, as well 
as ETS Hidden Patterns and Identical Pictures, and 
Thurstone Picture Memory.
Heritability Comparisons Between Schizophrenia and 
Nonpsychiatric Samples
Comparison of heritability estimates from schizophre-
nia and nonpsychiatric samples indicated that cognitive 
phenotypes do not have lower heritability in patients, in 
contrast to what has been thought due to environmen-
tal factors and illness-related moderators. Figure 4 shows 
the results from each study design for phenotypes that 
were meta-analyzed in the nonpsychiatric twin design 
and at least one other study design. Of the 15 phenotypes 
available in both schizophrenia and nonpsychiatric fam-
ily studies, 13 phenotypes did not significantly differ in 
heritability. Attention/Processing Speed had significantly 
lower heritability and Semantic Fluency had significantly 
higher heritability in schizophrenia families compared 
to nonpsychiatric families (Wald test P = 3.5 × 10−4 and 
P  =  3.9  ×  10−5). However, the difference in Semantic 
Fluency may not be accurate, as it was driven by low heri-
tability in nonpsychiatric families based on only 2 stud-
ies. Heritability estimates also did not markedly differ 
between 15 phenotypes available in nonpsychiatric twin 
and family designs, with only WAIS Digit Symbol Coding 
and Semantic Fluency having significantly lower herita-
bility in families than twins (Wald test P = 7.3 × 10−6 and 
P = 1.0 × 10−3). The CIs of the heritability estimates were 
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Fig. 1. Variance component estimates for cognitive phenotypes based on meta-analysis of nonpsychiatric twin studies. Percentage 
variance explained by A (Additive genetic influences), C (Common environment), and E (Unique environment and Error) for individual 
test variables (plain font) and cognitive domains (bold font). Error bars and numbers in parentheses indicate 95% CIs. The sample size 
for a given cognitive domain differs from the summed sample size for test variables within that domain because inclusion criteria differ 
(supplementary methods).
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typically narrower for phenotypes with larger numbers of 
studies and larger total sample sizes, as expected. Taking 
the sample sizes into account, heritability estimates 
appeared equally precise for schizophrenia and nonpsy-
chiatric studies.
Genetic Overlap Between Schizophrenia Liability and 
Cognition
To assess the genetic overlap between schizophrenia 
liability and cognitive functions, we summarized data 
reported in the Maudsley Twin and Family Studies and 
by the overarching Schizophrenia Twins and Relatives 
Consortium (STAR Consortium),44 a series of studies 
of twins and other family members concordant or dis-
cordant for schizophrenia (supplementary table  8).33–38 
Figure 5 shows the cross-twin-cross-trait correlations, ie, 
the correlations between phenotype 1 in co-twin 1 and 
phenotype 2 in co-twin 2, and vice versa.36,37 Significantly 
larger cross-twin-cross-trait correlations for MZ twin 
pairs (rMZCT–CT) than for DZ twins (rDZCT–CT) resulted 
in greater genetic overlap (rg) with schizophrenia liabil-
ity, as noted for verbal and nonverbal memory mea-
sures (Logical Memory [−.34 to −.58], Verbal Paired 
Associates [−.26 to −.50], and Visual Reproduction [−.34 
to −.99]), Full-scale IQ (−.46 to −.69), and WAIS Index 
Scores (−.34 to −.79), which are major components of 
IQ. Some cognitive phenotypes had very high genetic cor-
relations, (rg > .8, Trail Making Test A and B, Semantic 
Fluency) which may be overestimations since the CIs for 
those correlations were relatively wide (supplementary 
table  8). The genetic overlap between cognitive pheno-
types and schizophrenia liability ranged widely, possibly 
due to small samples causing imprecise estimates, but 
overall was relatively high (average rg = −.58; SD = 0.22).
Discussion
This study reports a comprehensive meta-analysis of her-
itability data across cognitive domains in nonpsychiatric 
individuals and those with schizophrenia. We confirm 
the high heritability of multiple cognitive domains and 
demonstrate that this applies to both schizophrenia and 
nonpsychiatric samples. To our knowledge, this is the first 
systematic, meta-analytic demonstration that the heri-
tabilities of cognitive phenotypes in schizophrenia are 
equivalent to those in healthy populations.
The most heritable phenotypes (h2 > 64%) were 
IQ, Spearman’s “g,” and some WAIS index scores 
that comprise IQ (Verbal Comprehension, Perceptual 
Organization), as well as tests that comprise or are highly 
correlated with IQ, such as WAIS Vocabulary and Block 
Design (h2 = 57%–60%). Interestingly, phenotypes within 
the Attention/Processing Speed domain differed substan-
tially in heritability, with measures indexing information 
processing speed (eg, Digit Symbol Coding, ETS Hidden 
Patterns) having relatively high heritability (h2  =  59%–
74%), and timed measures dependent on motor response 
having lower heritability (h2 = 28%–50%). For the most 
part, tests that we considered indexes of executive 
Fig. 2. Variance component estimates for cognitive phenotypes based on meta-analysis of nonpsychiatric family studies. Percentage 
variance explained by A + C (Additive genetic + Common environment influences) and E (Unique environment and Error) for individual 
test variables (plain font) and cognitive domains (bold font). A and C are combined because they cannot be disentangled in the family 
design. Error bars and numbers in parentheses indicate 95% CIs. The sample size for a given cognitive domain differs from the summed 
sample size for test variables within that domain because inclusion criteria differ (supplementary methods).
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Fig. 3. Variance component estimates for cognitive phenotypes based on meta-analysis of schizophrenia family studies. Percentage 
variance explained by A + C (Additive genetic + Common environment influences) and E (Unique environment and Error) for individual 
test variables (plain font) and cognitive domains (bold font). A and C are combined because they cannot be disentangled in the family 
design. Error bars and numbers in parentheses indicate 95% CIs. The sample size for a given cognitive domain differs from the summed 
sample size for test variables within that domain because inclusion criteria differ (supplementary methods).
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Fig. 4. Heritability of cognitive phenotypes across study designs. Phenotypic variance explained was determined by meta-analysis for 
nonpsychiatric twin, nonpsychiatric family, and schizophrenia family studies, or from the original study estimates for schizophrenia twin 
studies. Cognitive domains (bold) and test variables (plain) meta-analyzed in the nonpsychiatric twin and at least one other study design 
are shown. Error bars indicate 95% CIs. *P < .05 (Bonferroni-corrected). WCST = Wisconsin Card Sorting Test; CVLT = California 
Verbal Learning Test; IR, DR = Immediate, Delayed Recall.
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functioning (eg, Wisconsin Card Sorting Test, Tower of 
London) had relatively low heritability (h2 = 20%–40%). 
Given the multifactorial nature of neuropsychological 
tests, our categorization of tests into cognitive domains 
is not the only possible arrangement. For example, 
Stroop Interference and Trail Making Test B could be 
grouped into the Executive Function domain instead of 
the Attention/Processing Speed domain; however, doing 
so would not increase the Executive Function heritabil-
ity estimate since the heritability of these tests was also 
low. Thus, we provided individual test data in the tables 
to enable evaluation of test-specific heritability estimates, 
in addition to domain estimates.
The fact that we report substantial heritability across 
cognitive phenotypes has important implications. While 
high heritability does not indicate that any particular gene 
has a large effect on the phenotype, it does suggest that the 
phenotype has a sizeable genetic component that improves 
precision for defining gene function in cognition. The 
range in heritability across phenotypes could result from 
differences in genetic architecture, where different genes 
and/or the same genes with different effects (possibly due 
Fig. 5. Genetic overlap between cognitive phenotypes and schizophrenia liability based on twin data. Cross-twin cross-trait (CT–CT) 
correlations for cognition in co-twin 1 and schizophrenia liability in co-twin 2 for MZ pairs (rMZCT–CT) and DZ pairs (rDZCT–CT). rph is 
the total phenotypic correlation between the cognitive phenotype and schizophrenia liability, of which rph-a is the amount due to additive 
genetic influences. rg is the genetic correlation between the cognitive phenotype and schizophrenia liability. All correlations are negative 
(ie, poor cognition associated with high liability) but are shown as positive values for plotting consistency. Data are maximum likelihood 
estimates reported in references.34–37 Study reference numbers are shown in parentheses. CT–CT correlations were only reported for 
studies Toulopoulou et al36 and Toulopoulou et al.37 FIQ and WMS subtests were analyzed in multiple studies; only data from studies 
reporting CT–CT correlations are shown. See supplementary table 8 for all reported data. FIQ = Full-Scale Intelligence Quotient; IR, 
DR = Immediate, Delayed Recall; WAIS = Wechsler Adult Intelligence Scale; WMS = Wechsler Memory Scale.
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to different genetic variants) mediate the phenotypes. 
Alternatively, differences in environmental effects or mea-
surement error between phenotypes could affect heritabil-
ity, since heritability is a proportion of the total phenotypic 
variance, which also comprises variance due to common 
environment (C), and unique environment and measure-
ment error (E). Measurement error is likely not a major 
factor, however, since test–retest reliability is generally 
high (intra-class correlations > .7) for most neuropsycho-
logical tests.45–48 An exception is Executive Function tasks 
that tend to have low reliability49,50 (eg, intra-class correla-
tions < .7 for WCST indices51). This might be due to their 
sensitivity to practice effects,50,52 which may explain their 
relatively low heritability in our meta-analyses. In con-
trast, environmental factors have substantial influences on 
some cognitive phenotypes; eg, verbal tests are particu-
larly sensitive to education and socioeconomic status.53,54 
In reality, both genetic and environmental factors likely 
underlie the range in heritability observed across the cog-
nitive phenotypes. An important implication is that cog-
nitive phenotypes with similar degrees of genetic effects 
could differ in heritability due to different environmental 
effects, a notion that is typically not appreciated by heri-
tability studies, which tend to invoke genetic explanations 
for heritability differences.
The current study also compared heritability between 
schizophrenia and nonpsychiatric study designs and did 
not find consistent differences. This is perhaps the most 
important and novel finding of this study, and has several 
important implications. First, similar heritability suggests 
that genetic factors contributing to schizophrenia do not 
disrupt normal genetic influences on cognition in the gen-
eral population. Second, it suggests that schizophrenia 
and nonpsychiatric samples should be equally informative 
for genetic studies of cognition. Third, similar heritability 
indicates that illness-related moderators (eg, medication, 
higher rates of smoking and substance use in patients) 
and environmental factors, which are often assumed to 
have larger effects in schizophrenia samples, have negli-
gible effects on heritability. However, the lack of marked 
differences between schizophrenia and nonpsychiatric 
samples in the measurement accuracy of neuropsycho-
logical tests46–48 suggests that fluctuations in illness-related 
moderators have negligible effects on cognitive perfor-
mance. While there is some evidence that illness-related 
moderators affect some cognitive domains,55–59 2 large 
cohort studies did not find consistently higher variances 
in several cognitive phenotypes in schizophrenia patients 
compared to healthy subjects (eg, BACS composite score, 
Continuous Performance Test, CVLT, Letter–Number 
Sequencing).60–63 Also, we found similar CI widths for 
heritability estimates of cognitive phenotypes across 
schizophrenia and nonpsychiatric samples, indicating that 
heritability in schizophrenia samples is fairly consistent 
despite differences in environmental factors and illness-
related moderators (due to differences in ascertainment, 
inclusion/exclusion criteria, etc.). Therefore, the degree to 
which genetic studies of cognition in schizophrenia will 
be informative for elucidating the biology and informing 
novel treatment approaches for cognitive impairment will 
depend on the variance explained by genetic factors (ie, 
the heritability), rather than illness-related moderators 
and environmental factors. This is an important issue 
because it is commonly thought that environmental fac-
tors and illness-related moderators hinder the detection 
of genetic effects in schizophrenia samples. For this rea-
son, some studies have focused on unaffected relatives 
of patients, who carry genetic risk for schizophrenia 
and have impaired cognition (although less severe than 
patients),9,64–67 but lack or have milder illness-related mod-
erators, as a means to examine the genetics of cognition 
in schizophrenia. Instead, similar heritability suggests 
that studying schizophrenia samples is valuable and, some 
might argue, more informative for understanding the rela-
tionship between cognition and schizophrenia.
Some cognitive domains that are impaired in schizo-
phrenia1,4 are relatively understudied genetically, particu-
larly Social Cognition, Attention/Vigilance, Nonverbal 
Memory, and Executive Function. Fewer studies and 
smaller sample sizes can lead to inaccurate heritability 
estimates that may explain, in part, the low heritability 
observed for some of these domains. Heritability could 
be inaccurate in family studies since they do not distin-
guish influences of genetic effects (A) and common envi-
ronment (C); therefore, these influences are combined 
into “familiality.” However, the lack of consistent dif-
ferences in heritability using a family design compared 
to the MZ/DZ twin design suggests that C has negligible 
influence on most cognition phenotypes. Thus, for family 
studies, A+C is almost entirely A, and “familiality” is a 
good proxy for heritability.
An emerging method to estimate heritability utilizes 
population-based SNP data to determine the collective 
variance in a phenotype that is explained by common 
genetic variation.68,69 SNP-based heritability of cognitive 
phenotypes in adults is estimated to be 29% for General 
Cognitive Ability (Spearman’s g)70 and 19%–56% for 
other cognitive phenotypes.71–76 These estimates are lower 
than those from our meta-analyses, but in line with a twin 
study that reported considerably lower heritability esti-
mated from SNP data than from variance components.73 
This “missing heritability” suggests that other inherited 
factors not indexed by SNPs, such as rare variants and 
structural variation, as well as heritable epigenetic modi-
fications and other factors, contribute to individual vari-
ation in cognitive phenotypes.77 It will be important to 
develop analytical methods that incorporate other poten-
tial sources of genetic variation to estimate heritability 
using population-based approaches.
We also examined the genetic overlap between cognitive 
phenotypes and schizophrenia liability from a summary 
of schizophrenia twin studies.33–38 We found moderate to 
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high genetic correlations (average rg  =  −.58), consistent 
with a previous report of significant correlations between 
several cognitive domains and negative symptoms and 
disorganization.78 However, the twin study genetic cor-
relations ranged widely across phenotypes, possibly due 
to small samples causing imprecise estimates, or because 
some cognitive constructs have stronger genetic relation-
ships to schizophrenia than others. The genetic overlap 
suggests that shared genes regulate neurodevelopmen-
tal processes mediating both cognition and psychosis.79 
Alternatively, the genes may have pleiotropic effects 
reflecting multiple roles in neural processes that govern 
cognition and other mechanisms underlying schizophre-
nia. In an attempt to assess causality between cognition 
and schizophrenia liability, Toulopoulou et al38 performed 
multivariate structural equation modeling in schizophre-
nia twin-family samples and found evidence that cognitive 
deficits lie upstream of liability, with a genetic correlation 
of −.51. Population-based studies also support genetic 
overlap of cognition with schizophrenia liability, although 
possibly lower (eg, genetic correlation of −.26)80 than that 
estimated by schizophrenia studies. Molecular genetic 
overlap between cognition and schizophrenia is sup-
ported by recent GWAS mega-analyses.19,81–83 Specifically, 
polygenic variation influencing cognitive functioning in 
healthy cohorts was significantly associated with schizo-
phrenia case status in independent datasets.19 In paral-
lel, polygenic risk for schizophrenia was significantly 
associated with poorer cognition in healthy cohorts.81–83 
These studies suggest that polygenic variants influencing 
schizophrenia risk modulate neural processes involved in 
cognition in the general population, although the contri-
bution is small (explaining <1% variance in cognition).81–83 
It is conceivable that schizophrenia genetic factors have 
a stronger impact on cognition in patients, possibly 
because dysfunctional neural circuits are more sensitive 
to the genetic effects than normally functioning circuits. 
Unfortunately, the few patient studies examining schizo-
phrenia genetic variants in cognition produced incon-
sistent results, possibly due to small sample sizes.84–86 In 
addition, there have been no studies specifically examining 
the genetic basis of the degree of cognitive impairment 
in patients separate from the genetic basis of cognitive 
ability. While schizophrenia risk genes may influence the 
degree of impairment, as suggested by the presence of 
cognitive deficits in unaffected relatives genetically pre-
disposed to schizophrenia,9,64–67 other genes that are not 
causal in schizophrenia may be involved. Indeed, the par-
tial genetic overlap between cognition and schizophrenia 
liability indicates that genes not involved in schizophrenia 
also have a substantial influence on cognition.
It is unclear whether cognition genes have the same 
effects in schizophrenia and nonpsychiatric populations, or 
whether the effects vary despite heritability being similar. It 
may be that different genes support cognition in schizo-
phrenia and healthy individuals, possibly due to pleiotropy 
or due to genes being inactive under certain conditions. 
While there has been considerable effort to elucidate the 
genetic architecture of cognition in nonpsychiatric popu-
lations,43,70,81,87 there is a dearth of high-powered genetic 
studies of cognition in schizophrenia samples. Analyses of 
large, well-phenotyped samples consisting of both patients 
and healthy individuals, which we are actively undertak-
ing, will be important to clarify this issue. If the same 
genes influence cognition in schizophrenia patients and the 
general population, the neural mechanisms regulated by 
these genes may nonetheless operate differently in patients, 
perhaps due to genetic variation associated with cognitive 
impairment. A similar genetic basis in schizophrenia and 
nonpsychiatric populations would not invalidate cogni-
tive markers as endophenotypes of schizophrenia, since 
cognitive deficits in patients meet the criteria for endo-
phenotypes notwithstanding.28 Cognition is a particularly 
important endophenotype because delineating its underly-
ing genetic mechanisms may identify promising targets for 
improving cognitive functioning in patients.
At this time, it is difficult to recommend specific neu-
ropsychological tests or cognitive domains that are the 
most appropriate for examining the genetic basis of cog-
nition in schizophrenia. This judgment depends on both 
the heritability of the phenotype and its genetic overlap 
with schizophrenia. Our meta-analyses identified several 
cognitive phenotypes having high heritability, such as IQ, 
Spearman’s g, and WAIS index scores mentioned above, 
which could be prioritized for genetic studies. However, 
the genetic correlation data from twin studies are too 
limited to conclusively identify phenotypes having the 
largest genetic overlap with schizophrenia. Similarly, 
analyses of the effects of schizophrenia risk genes and 
polygenic factors across multiple cognitive phenotypes 
are limited, although 2 recent studies reported that poly-
genic risk explains more variance in Attention/Language 
than Verbal Memory,83 and Performance IQ than Verbal 
IQ and Full-Scale IQ.82 Additional studies are required 
to determine which cognitive phenotypes have the stron-
gest genetic relationships to schizophrenia and are most 
appropriate as markers for studying the genetics of cogni-
tion in schizophrenia.
Recent studies have also identified genetic overlap of 
cognitive phenotypes with brain structural phenotypes.38 
Further, the heritability of specific cognitive abilities 
is comparable to the heritability of volume and corti-
cal thickness of brain structures subserving those abili-
ties,88,89 many of which involve the prefrontal cortex. 
Schizophrenia onset during adolescence and early adult-
hood coincides with the maturation of brain regions 
that are abnormal in schizophrenia, such as the tempo-
ral and frontal lobes.90–92 Indeed a putative mechanism 
underlying schizophrenia might be mistiming of brain 
maturation processes that are important for higher order 
cognitive functions.93 Brain maturational stages would 
therefore be important to consider when interpreting 
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genetic relationships between schizophrenia and cogni-
tion or other phenotypes. It would also be important to 
consider sex differences in cognitive deficits given known 
sexual dimorphism in normal neurodevelopmental pro-
cesses and their timing, as well as those associated with 
schizophrenia.94
Conclusions
Taken together, our results show that most cognitive 
phenotypes have moderate to high heritability, although 
estimates range widely, likely due to differences in both 
genetic and environmental influences. Our results also 
indicate that heritability of cognitive phenotypes does not 
markedly differ between schizophrenia and nonpsychiat-
ric populations, suggesting that schizophrenia samples 
are valuable for studying the genetic basis of cognitive 
impairment in patients. Genetic overlap between schizo-
phrenia and cognitive phenotypes supports a shared 
genetic etiology; however, more studies are required to 
verify whether the same genes influence cognitive varia-
tion in schizophrenia patients and the general population.
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